Endocarditis After Transcatheter Pulmonary Valve Replacement.
暂无分享,去创建一个
D. McElhinney | P. Ewert | R. Padera | F. Berger | A. Eicken | L. Søndergaard | T. Jones | R. Gray | E. Zahn | W. Hellenbrand | J. Kreutzer | D. Balzer | L. Bergersen | Aimee K. Armstrong | T. Lung | Robert G Gray
[1] L. Køber,et al. Incidence of infective endocarditis among patients considered at high risk , 2018, European heart journal.
[2] H. Laks,et al. Incidence and outcome of infective endocarditis following percutaneous versus surgical pulmonary valve replacement , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[3] K. Dimopoulos,et al. Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015 , 2017, PloS one.
[4] J. Riou,et al. Infective Endocarditis Risk After Percutaneous Pulmonary Valve Implantation With the Melody and Sapien Valves. , 2017, JACC. Cardiovascular interventions.
[5] D. McElhinney. Reflection and Rationalization: Making Sense of the Literature on Endocarditis After Transcatheter Pulmonary Valve Replacement , 2017, Circulation. Cardiovascular interventions.
[6] P. Ewert,et al. Five-year results from a prospective multicentre study of percutaneous pulmonary valve implantation demonstrate sustained removal of significant pulmonary regurgitation, improved right ventricular outflow tract obstruction and improved quality of life. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[7] A. Zwinderman,et al. Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material , 2017, European heart journal.
[8] J. Rome,et al. Transcatheter Pulmonary Valve Replacement Reduces Tricuspid Regurgitation in Patients With Right Ventricular Volume/Pressure Overload. , 2016, Journal of the American College of Cardiology.
[9] L. Baddour,et al. Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. , 2016, European heart journal cardiovascular Imaging.
[10] N. Wilson,et al. Infective endocarditis following Melody valve implantation: comparison with a surgical cohort , 2016, Cardiology in the Young.
[11] C. Fraser,et al. Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. , 2016, The Journal of thoracic and cardiovascular surgery.
[12] E. Tuzcu,et al. Response to Letters Regarding Article, "Infective Endocarditis After Transcatheter Aortic Valve Implantation: Results From a Large Multicenter Registry". , 2015, Circulation.
[13] R. Baltimore,et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association , 2015, Circulation.
[14] S. Pasquali,et al. The Utility of Intracardiac Echocardiography Following Melody™ Transcatheter Pulmonary Valve Implantation , 2015, Pediatric Cardiology.
[15] M. Jacobs,et al. Benchmark Outcomes for Pulmonary Valve Replacement Using The Society of Thoracic Surgeons Databases. , 2015, The Annals of thoracic surgery.
[16] J. Cheatham,et al. Clinical and Hemodynamic Outcomes up to 7 Years After Transcatheter Pulmonary Valve Replacement in the US Melody Valve Investigational Device Exemption Trial , 2015, Circulation.
[17] H. Bundgaard,et al. Prosthetic Valve Endocarditis After Transcatheter Aortic Valve Implantation , 2015, Circulation. Cardiovascular interventions.
[18] B. Eyskens,et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants , 2014, Heart.
[19] L. Iserin,et al. Incidence and outcomes of right-sided endocarditis in patients with congenital heart disease after surgical or transcatheter pulmonary valve implantation. , 2014, The Journal of thoracic and cardiovascular surgery.
[20] J. Rome,et al. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. , 2014, JACC. Cardiovascular interventions.
[21] M. Chen,et al. Effects of transcatheter pulmonary valve replacement on the hemodynamic and ventricular response to exercise in patients with obstructed right ventricle-to-pulmonary artery conduits. , 2014, JACC. Cardiovascular interventions.
[22] H. Bundgaard,et al. Infective endocarditis following percutaneous pulmonary valve replacement: diagnostic challenges and application of intra-cardiac echocardiography. , 2013, International journal of cardiology.
[23] J. Cheatham,et al. The medtronic melody® transcatheter pulmonary valve implanted at 24‐mm diameter—it works , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[24] J. Kaufman,et al. Infective Endocarditis in Children With Congenital Heart Disease: Cumulative Incidence and Predictors , 2013, Circulation.
[25] D. Raoult,et al. Positron emission tomography/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion. , 2013, Journal of the American College of Cardiology.
[26] D. McElhinney,et al. Infective Endocarditis After Transcatheter Pulmonary Valve Replacement Using the Melody Valve: Combined Results of 3 Prospective North American and European Studies , 2013, Circulation. Cardiovascular interventions.
[27] K. Gauvreau,et al. Bloodstream Infections Occurring in Patients With Percutaneously Implanted Bioprosthetic Pulmonary Valve: A Single-center Experience , 2013, Circulation. Cardiovascular Interventions.
[28] L. Iserin,et al. Atypical malignant late infective endocarditis of Melody valve. , 2012, The Journal of thoracic and cardiovascular surgery.
[29] J. Cheatham,et al. Short- and Medium-Term Outcomes After Transcatheter Pulmonary Valve Placement in the Expanded Multicenter US Melody Valve Trial , 2010, Circulation.
[30] R. Weber,et al. Interventions Using Foreign Material to Treat Congenital Heart Disease in Children Increase the Risk for Infective Endocarditis , 2008, The Pediatric infectious disease journal.
[31] R. Razavi,et al. Percutaneous Pulmonary Valve Implantation in Humans: Results in 59 Consecutive Patients , 2005, Circulation.
[32] P. Bonhoeffer,et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction , 2000, The Lancet.
[33] V. Fowler,et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] W. Foss,et al. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis , 1996, Infection and immunity.
[35] S. Jockenhoevel,et al. Bacterial adherence to graft tissues in static and flow conditions , 2018, The Journal of thoracic and cardiovascular surgery.
[36] V. Rousson,et al. Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans? , 2015, The Journal of infectious diseases.
[37] G. Stein,et al. Positron emission tomography/computed tomography for the diagnosis of endocarditis in patients with pulmonic stented valve/pulmonic stent. , 2011, The Annals of thoracic surgery.